Elena Gargaun et al.
The lncRNA 44s2 Study Applicability to the Design of 45-55 Exon Skipping Therapeutic Strategy for DMD
Biomedicines 2021, vol. 9, issue 2
doi: 10.3390/biomedicines9020219
![Logo France Génomique](https://www.france-genomique.org/wp-content/uploads/2019/03/logo-FG-blue-RVB-medium.png)
Elena Gargaun et al.
The lncRNA 44s2 Study Applicability to the Design of 45-55 Exon Skipping Therapeutic Strategy for DMD
Biomedicines 2021, vol. 9, issue 2
doi: 10.3390/biomedicines9020219